LONDON (Reuters) - AstraZeneca is stepping up a drive to wring value out of the business with plans to sell its Astra Tech dental implants and medical devices unit for some $2 billion.
LONDON (Reuters) - AstraZeneca is stepping up a drive to wring value out of the business with plans to sell its Astra Tech dental implants and medical devices unit for some $2 billion.
